Lifeward (LFWD) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.35% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.46% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -26.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.51% |
| Dec 31, 2025 | -32.53% |
| Sep 30, 2025 | -47.33% |
| Jun 30, 2025 | -41.93% |
| Mar 31, 2025 | -35.57% |
| Dec 31, 2024 | -31.30% |
| Sep 30, 2024 | 16.24% |
| Jun 30, 2024 | 874.42% |
| Mar 31, 2024 | 653.75% |
| Dec 31, 2023 | 543.88% |
| Sep 30, 2023 | 341.77% |
| Jun 30, 2023 | -54.09% |
| Mar 31, 2023 | -47.88% |
| Dec 31, 2022 | -30.99% |
| Sep 30, 2022 | -21.78% |
| Jun 30, 2022 | -20.85% |
| Mar 31, 2022 | -21.68% |
| Dec 31, 2021 | -35.01% |
| Sep 30, 2021 | -36.08% |
| Jun 30, 2021 | -20.58% |
| Mar 31, 2021 | -19.18% |
| Dec 31, 2020 | -12.77% |
| Sep 30, 2020 | -1.25% |
| Jun 30, 2020 | -1.32% |
| Mar 31, 2020 | -8.83% |
| Dec 31, 2019 | -19.97% |
| Sep 30, 2019 | -34.07% |
| Jun 30, 2019 | -40.55% |
| Mar 31, 2019 | -29.63% |
| Dec 31, 2018 | -25.48% |
| Sep 30, 2018 | -19.65% |
| Jun 30, 2018 | -28.65% |
| Mar 31, 2018 | -32.32% |
| Dec 31, 2017 | -33.23% |
| Sep 30, 2017 | -32.69% |
| Jun 30, 2017 | -26.40% |
| Mar 31, 2017 | -13.68% |
| Dec 31, 2016 | -5.27% |
| Jun 30, 2016 | 44.96% |
| Dec 31, 2015 | 220.77% |
| Dec 31, 2014 | 16.29% |